Balyasny Asset Management
CELL

Balyasny Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Balyasny Asset Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-34,282
Closed -$34.2K – 3044
2023
Q3 		$34.2K Buy
34,282
+18,792
+121% +$14.4K ﹤0.01% 2167
2023
Q2 		$7.59K Buy
+15,490
New +$12.7K ﹤0.01% 2189
2022
Q1 		– Sell
-16,827
Closed -$306K – 2983
2021
Q4 		$306K Buy
+16,827
New +$363K ﹤0.01% 1738

Balyasny Asset Management's CELL Position: Q4 2023 in Review

Balyasny Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 34,282 shares — an estimated $34.2K sold.

Balyasny Asset Management first reported a position in CELL in Q4 2021 and held it in 3 quarters. The position peaked at $306K in Q4 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Balyasny Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 34,282 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $34.2K.
  • Balyasny Asset Management first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Balyasny Asset Management's PhenomeX Inc. Common Stock position peaked at $306K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Balyasny Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.